
Zensita Trio 10mg/1000mg/100mg Tablet ER
Marketer
Zuventus Healthcare Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg)
Overview Zensita Trio 10mg/1000mg/100mg Tablet ER
Tri-Zyme 10/1000/100mg Extended-Release Tablets are a combined medication designed to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Tri-Zyme 10/1000/100mg ER can be ingested with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their approval, as abrupt cessation may elevate blood sugar and increase risks such as kidney impairment and vision loss. This medication forms part of a broader treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include upper respiratory infections, sore throat, nasal congestion, and urinary tract infections. Adequate hydration helps prevent dehydration. Genital yeast infections may occur; good hygiene can mitigate this risk. Prior to commencing Tri-Zyme 10/1000/100mg ER, discuss any kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption, as it may intensify certain side effects. Regular blood sugar monitoring is crucial while taking this medication.
Primary Ingredients of Zensita Trio 10mg/1000mg/100mg Tablet ER
No text was provided. Please provide the text you wish me to rephrase.
Uses of Zensita Trio 10mg/1000mg/100mg Tablet ER
Managing type 2 diabetes
Major Benefits of Zensita Trio 10mg/1000mg/100mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Zensita Trio 10mg/1000mg/100mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While consumption with or without food is acceptable, consistent daily timing is recommended.
Common Side effects of Zensita Trio 10mg/1000mg/100mg Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Zensita Trio 10mg/1000mg/100mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Zensita Trio 10mg/1000mg/100mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, however, consistent daily timing is recommended.
How Zensita Trio 10mg/1000mg/100mg Tablet ER works:
Zensita Trio Extended-Release tablets (10mg/1000mg/100mg) combine three anti-hyperglycemic agents. Dapagliflozin enhances glucose elimination via the kidneys, lowering blood sugar. Metformin reduces both dietary glucose absorption and hepatic glucose production. Furthermore, it improves insulin sensitivity, boosting the body's natural blood glucose regulation. Sitagliptin regulates blood glucose by stimulating incretin production, thereby increasing insulin release from the pancreas and suppressing hepatic glucose output when blood sugar is elevated.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Zensita Trio 10mg/1000mg/100mg Extended-Release Tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of Zensita Trio 10mg/1000mg/100mg Extended-Release tablets is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Zensita Trio 10mg/1000mg/100mg extended-release tablets and breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Zensita Trio 10mg/1000mg/100mg Tablet ER is undetermined. Refrain from driving if concentration or reaction times are impaired.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zensita Trio 10mg/1000mg/100mg Extended-Release tablets to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zensita Trio 10mg/1000mg/100mg Extended-Release tablets to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Zensita Trio 10mg/1000mg/100mg Tablet ER :
NA
Facts to Know About Zensita Trio 10mg/1000mg/100mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
